SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCalculus Vct Regulatory News (CLC)

Share Price Information for Calculus Vct (CLC)

Share Price is delayed by 15 minutes
Get Live Data
53.25    0.00 (0.00%)
Bid:
48.00
Ask:
58.50
Spread: 10.50 (21.875%)
Market Cap: £51.93m
CLC Live PriceLast checked at - London Stock Exchange

Intraday Calculus Vct Share Chart

GM Statement

31 Aug 2017 11:20

RNS Number : 4452P
Calculus VCT PLC
31 August 2017
 

Calculus VCT plc

(the "Company")

 

GM Results

 

31 August 2017

 

This announcement is made by the Company in connection with the proposed merger of the Company with Neptune-Calculus Income and Growth VCT plc ("Neptune") (the "Merger"). The merger will be completed by way of a scheme of reconstruction of Neptune pursuant to section 110 of the Insolvency Act 1986 whereby Neptune will be placed in members' voluntary liquidation and all of its assets and liabilities transferred by its appointed liquidators to the Company in consideration for the issue of new shares in the Company to the shareholders of Neptune. Full details of the merger were contained in the Company's circular to shareholders ("Circular") dated 4 August 2017.

 

The Board is pleased to announce that at the general meeting of the Company held on 31 August 2017, all proposed resolutions set out in the Circular, including the resolution to approve the acquisition of the assets and liabilities of Neptune and to authorise the issue of new shares in the Company to the shareholders of Neptune, were duly passed on a show of hands. Proxy votes received in respect of each resolution were as follows:

 

 

Resolution 1 - Approval of the Merger

 

Votes

Number of Shares

 

Percentage of Votes Cast

For and Chairman's Discretion

1,173,581

85%

Against

213,115

15%

Withheld

0

0%

 

Resolution 2 - Authority to allot new Ordinary Shares pursuant to the Offer

 

Votes

Number of Shares

 

Percentage of Votes Cast

For and Chairman's Discretion

1,386,696

100%

Against

0

0%

Withheld

0

0%

 

Resolution 3 - Disapplication of pre-emption rights

 

Votes

Number of Shares

 

Percentage of Votes Cast

For and Chairman's Discretion

1,173,581

85%

Against

213,115

15%

Withheld

0

0%

 

Resolution 4 - Reduction of share premium account

 

Votes

Number of Shares

 

Percentage of Votes Cast

For and Chairman's Discretion

1,173,581

85%

Against

213,115

15%

Withheld

0

0%

 

Resolution 5 - Amendments to the Company's articles of association

 

Votes

Number of Shares

 

Percentage of Votes Cast

For and Chairman's Discretion

1,173,581

85%

Against

213,115

15%

Withheld

0

0%

 

Resolution 6 - Approval of amendments to investment management agreement with Calculus Capital Limited

 

Votes

Number of Shares

 

Percentage of Votes Cast

For and Chairman's Discretion

1,149,785

84%

Against

213,115

16%

Withheld

23,796

0%

 

 

A copy of the resolutions passed at the above meeting will shortly be available for inspection on both the Company's website (www.calculuscapital.com/calculus-vct-plc/) as well as at the National Storage Mechanism (www.morningstar.co.uk/uk/NSM).

 

Total Voting Rights

In conformity with the Disclosure Guidance and Transparency Rules, Calculus confirms that the Company's issued share capital consists of 8,825,947 Ordinary Shares with a nominal value of 1p each, with voting rights. The Company does not hold any shares in treasury and therefore, the total number of voting rights is 8,825,947 and this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Calculus Capital Limited

Company Secretary

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
GMSLLFLITTILVID
Date   Source Headline
5th Apr 201811:56 amRNSIssue of Equity
4th Apr 20183:20 pmRNSIssue of Equity
11th Jan 20185:53 pmRNSTransaction in Own Shares
9th Jan 20186:02 pmRNSTransaction in Own Shares
3rd Jan 20182:56 pmRNSTransaction in Own Shares
20th Dec 201712:06 pmRNSIssue of Equity
18th Dec 201712:47 pmRNSNet Asset Value(s)
1st Nov 20174:28 pmRNSStatement re Cancellation of Share Premium Account
26th Oct 20179:28 amRNSDirector Declaration
23rd Oct 20173:56 pmRNSHalf-year Report
23rd Oct 20172:12 pmRNSOffer Update
12th Sep 20173:50 pmRNSMerger Results and Issue of Equity
31st Aug 201711:20 amRNSGM Statement
29th Aug 20173:22 pmRNSAGM Statement
16th Aug 20172:06 pmRNSTransfer of ISIN
4th Aug 20175:57 pmRNSFurther re merger
4th Aug 20175:57 pmRNSMerger and Offer for subscription
2nd Aug 20175:46 pmRNSNotice of AGM
1st Aug 20174:05 pmRNSConversion of Securities
25th Jul 201711:16 amRNSDividend Declaration
24th Jul 20174:23 pmRNSStatement re Share Class Merger
4th Jul 201710:57 amRNSDividend Declaration
30th Jun 20174:27 pmRNSNet Asset Value(s)
19th Jun 20177:00 amRNSStatement re Recommended Proposals for Merger
19th Jun 20177:00 amRNSStatement re Recommended Proposals for Merger
11th May 20176:18 pmRNSAnnual Financial Report
8th May 20174:46 pmRNSChange of Company Registrar
18th Apr 20174:26 pmRNSOfficial List Notice
7th Apr 20172:41 pmRNSIssue of Equity
5th Apr 20175:18 pmRNSIssue of Equity
1st Mar 20174:53 pmRNSIssue of Equity
9th Feb 201711:20 amRNSIssue of Equity
2nd Feb 20174:37 pmRNSResult of Equity Issue
31st Jan 201712:12 pmRNSIssue of Equity
26th Jan 201712:07 pmRNSDividend Declaration
19th Jan 20174:03 pmRNSResult of Meeting
20th Dec 20169:11 amRNSNet Asset Value(s)
25th Nov 20162:16 pmRNSPublication of a Prospectus
24th Oct 201611:30 amRNSIssue of Equity
24th Oct 201611:25 amRNSHalf-year Report
28th Sep 20169:28 amRNSOffer for subscription
26th Jul 20166:18 pmRNSResult of AGM
19th Jul 201610:11 amRNSNet Asset Value(s)
21st Jun 20167:00 amRNSAnnual Financial Report
3rd May 201610:28 amRNSIssue of Equity
27th Apr 20164:14 pmRNSExtension of Closing Date
4th Apr 201610:20 amRNSIssue of Equity
9th Mar 20167:00 amRNSIssue of Equity
26th Feb 20162:47 pmRNSDisclosure of Home Member State
21st Jan 20161:14 pmPRNChange of Registered Office & Corporate Secretary

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.